Found vs Enhance MD: Pricing, personalization, and compound options
Found vs Enhance MD pits a biology-first, insurance-friendly telehealth program against a flat-rate, low-entry-cost compound provider. Early verdict: Found focuses on personalized, medically supervised plans and insurance integration, while Enhance MD emphasizes the lowest first-month compound prices and flat-rate dosing.
How pricing and insurance compare in Found vs Enhance MD
Price is a primary difference. Found advertises getting started for as low as $39 and highlights that most insurance is accepted, with programs that may use insurance for branded GLP-1s or compounded GLP-1s where available. Enhance MD advertises semaglutide from $49 first month and tirzepatide from $99 first month, using a direct-pay model and flat-rate pricing with no escalation during titration. Enhance MD does not bill insurance.
Start Enhance MD from $49 first month
Clinical approach and personalization: Found vs Enhance MD
Found frames itself as a biology-first program that conducts medical evaluations to tailor plans around individual metabolic biology, including hormones, blood sugar regulation, sleep, and behavior. Enhance MD positions itself as clinician-directed compounds activating hormonal pathways for metabolic regulation and offers both semaglutide and tirzepatide on one platform, but the source emphasizes flat-rate compound pricing rather than a described holistic program focus.
Compound availability and regulatory notes
Both providers offer compounded GLP-1s. Found lists semaglutide and tirzepatide among offerings and explicitly states that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and are not available in all states. Enhance MD also offers compounded semaglutide and tirzepatide and includes the same regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Distinctive differences organized
- Insurance acceptance: Found accepts most insurance and handles insurance paperwork for some programs. Enhance MD operates direct-pay and does not bill insurance.
- Entry pricing: Found advertises starting as low as $39. Enhance MD advertises semaglutide from $49 first month and tirzepatide from $99 first month.
- Pricing model over time: Found references affordable monthly plans with variable structures and mentions pricing via insurance for branded GLP-1s. Enhance MD uses flat-rate pricing that stays the same at every dose with no escalation.
- Program focus: Found emphasizes a biology-first, personalized medically supervised program targeting hormones, metabolism, and lifestyle. Enhance MD emphasizes clinician-directed compounds and metabolic wellness with both compound options available on one platform.
- Claims and scale: Enhance MD cites treating 10,000+ patients. Found highlights insurance acceptance for many patients and specific program offers including Medicare Bridge options for some brand-name GLP-1s.
Comparison table: Found vs Enhance MD
| Criteria | Found | Enhance MD |
|---|---|---|
| Starting price | Get started for as low as $39 | Semaglutide from $49 first month; tirzepatide from $99 first month |
| Insurance | Most insurance now accepted; Found handles insurance paperwork | Does not bill insurance; direct-pay model |
| Pricing model | Affordable monthly plans; variable pricing and offers | Flat-rate pricing; same price at every dose, no escalation |
| Compounded GLP-1s | Offers compounded semaglutide and tirzepatide; not FDA-approved | Offers compounded semaglutide and tirzepatide; not FDA-approved |
| Clinical focus | Biology-first personalized medically supervised program | Clinician-directed compounds; metabolic wellness focus |
| Scale or reach | Claims insurance acceptance for a large share of Americans; Medicare Bridge program mentioned | 10,000+ patients treated |
Both providers state that prescriptions are subject to clinician review and clinical eligibility. Found includes specific program disclaimers about branded medications being approved for conditions other than weight. Enhance MD notes that the $49 and $99 rates are first-month introductory prices and that ongoing flat-rate pricing is higher.
Explore Found plans and insurance options
Patient experience and transparency in Found vs Enhance MD
Enhance MD highlights transparent flat-rate pricing so patients avoid dose escalation fees and can budget consistently. Found highlights a personalized program and handling insurance paperwork, including references to Medicare GLP-1 Bridge Program access for eligible Part D members for select brand-name GLP-1s, while also noting that insurance coverage, pricing and terms vary.
Conclusion: Found vs Enhance MD
In sum, Found vs Enhance MD reduces to a choice between a biology-first, insurance-integrated program with advertised starts as low as $39 and a direct-pay compound provider offering the lowest first-month semaglutide price from $49 and flat-rate pricing thereafter. Both offer compounded GLP-1s and note those compounds are not FDA-approved finished products.
Choose Found if you want a biology-first, personalized medically supervised program with assistance handling insurance and options that may include brand-name GLP-1s through coverage pathways. Choose Enhance MD if your priority is the lowest first-month compound price for semaglutide or tirzepatide and predictable flat-rate pricing with no escalation as dose increases.